植物疗法在阿尔茨海默氏病-一个叙事审查
Julia Piekarz1, Natalia Picheta1, Oliwia Burdan1
1Students' Scientific Association, Department of Paediatric Neurology, Medical University, 20-059 Lublin, Poland.
Biomedicines
|August 29, 2024
概括
阿尔茨海默病 (AD) 是一种进展性神经退行性疾病. 使用Curcuma longa和Panax人参等草药的植物疗法显示出对管理AD症状和改善患者生活质量的承诺.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 草药是一种草药.
背景情况:
- 阿尔茨海默病 (AD) 是痴呆的主要原因,影响全球数百万人,其特点是神经退行,β-粉样沉积和炎症.
- 阿尔茨海默病表现为认知障碍和功能衰退,影响患者和护理人员,目前的治疗只提供症状缓解和严重的全球经济负担.
- 即使在年轻人中,阿尔茨海默病的发病率越来越高,以及传统疗法的局限性,需要探索替代治疗方法.
研究的目的:
- 审查植物疗法的潜力,作为阿尔茨海默病的替代治疗方法.
- 为了识别和突出特定的草药与AD管理有前途的药理学特性.
- 在AD治疗的背景下,探索精选草药的神经保护,抗炎和抗氧化作用.
主要方法:
- 关于植物疗法和阿尔茨海默病的科学研究的文献综述.
- 对有关AD病理机制的草药的药理性质的研究分析.
- 专注于草药,包括长,Panax人参,Berberis和Crocus sativus等.
主要成果:
- 草药具有抗氧化,抗炎和神经保护性质,有利于AD.
- 长黄,Panax人参,Berberis和Crocus sativus在治疗AD方面表现出潜在的潜力.
- 植物疗法为解决AD的根本原因和症状提供了一个有希望的途径.
结论:
- 植物疗法,特别是使用特定的草药,为阿尔茨海默病治疗提供了可行的和潜在的有效替代方案.
- 这些草药可能提供一种积极的方法来管理认知衰退,并改善阿兹海默症患者的生活质量.
- 对草药化合物的进一步研究可能会导致对阿尔茨海默病的新疗法策略.
关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.贝贝里斯是贝贝里斯人.克罗库斯 (Crocus Crocus) 是一个有趣的植物.胡卜 胡卜 胡卜 胡卜 胡卜 胡卜人参就是一个人,人参就是一个人.植物疗法是一种植物疗法.更多相关视频
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
11.9K
06:34Author Spotlight: Stimulation-Based Approach to Improve Cerebral Blood Flow in Alzheimer's Model
Published on: June 2, 2023
1.1K
相关概念视频
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Alzheimer's Disease: Overview
454
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
454
Dementia
107
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
107
Parkinson's Disease: Overview
499
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
499
Parkinson's Disease: Treatment
239
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
239
Drug Therapy
40
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
40
